MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 233 filers reported holding MYRIAD GENETICS INC in Q4 2015. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $570,000 | +2900.0% | 12,395 | +2379.0% | 0.00% | – |
| Q2 2018 | $19,000 | +26.7% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $15,000 | -11.8% | 500 | -1.0% | 0.00% | – |
| Q4 2017 | $17,000 | -95.9% | 505 | -95.4% | 0.00% | -100.0% |
| Q3 2015 | $410,000 | -2.6% | 10,935 | -11.8% | 0.00% | 0.0% |
| Q2 2015 | $421,000 | -11.2% | 12,395 | -7.5% | 0.00% | -25.0% |
| Q1 2015 | $474,000 | – | 13,395 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |